Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

New Frontiers: ARID3a in SLE.

Garton J, Barron MD, Ratliff ML, Webb CF.

Cells. 2019 Sep 24;8(10). pii: E1136. doi: 10.3390/cells8101136. Review.

2.

Mechanistic Characterization of RASGRP1 Variants Identifies an hnRNP-K-Regulated Transcriptional Enhancer Contributing to SLE Susceptibility.

Molineros JE, Singh B, Terao C, Okada Y, Kaplan J, McDaniel B, Akizuki S, Sun C, Webb CF, Looger LL, Nath SK.

Front Immunol. 2019 May 20;10:1066. doi: 10.3389/fimmu.2019.01066. eCollection 2019.

3.

Insights From Analysis of Human Antigen-Specific Memory B Cell Repertoires.

Shah HB, Smith K, Wren JD, Webb CF, Ballard JD, Bourn RL, James JA, Lang ML.

Front Immunol. 2019 Jan 15;9:3064. doi: 10.3389/fimmu.2018.03064. eCollection 2018. Review.

4.

ARID3a gene profiles are strongly associated with human interferon alpha production.

Ratliff ML, Garton J, Garman L, Barron MD, Georgescu C, White KA, Chakravarty E, Wren JD, Montgomery CG, James JA, Webb CF.

J Autoimmun. 2019 Jan;96:158-167. doi: 10.1016/j.jaut.2018.09.013. Epub 2018 Oct 5.

5.

Expression and methylation data from SLE patient and healthy control blood samples subdivided with respect to ARID3a levels.

Ward JM, Ratliff ML, Dozmorov MG, Wiley G, Guthridge JM, Gaffney PM, James JA, Webb CF.

Data Brief. 2016 Aug 31;9:213-9. doi: 10.1016/j.dib.2016.08.049. eCollection 2016 Dec.

6.

Human effector B lymphocytes express ARID3a and secrete interferon alpha.

Ward JM, Ratliff ML, Dozmorov MG, Wiley G, Guthridge JM, Gaffney PM, James JA, Webb CF.

J Autoimmun. 2016 Dec;75:130-140. doi: 10.1016/j.jaut.2016.08.003. Epub 2016 Aug 10.

7.

The Transcription Factor ARID3a Is Important for In Vitro Differentiation of Human Hematopoietic Progenitors.

Ratliff ML, Mishra M, Frank MB, Guthridge JM, Webb CF.

J Immunol. 2016 Jan 15;196(2):614-23. doi: 10.4049/jimmunol.1500355. Epub 2015 Dec 18.

8.

Antibody Reactivity of B Cells in Lupus Patients with Increased Disease Activity and ARID3a Expression.

Ward JM, James JA, Zhao YD, Webb CF.

Antibodies (Basel). 2015 Dec;4:354-368. doi: 10.3390/antib4040354. Epub 2015 Nov 17.

9.

A developmentally plastic adult mouse kidney cell line spontaneously generates multiple adult kidney structures.

Webb CF, Ratliff ML, Powell R, Wirsig-Wiechmann CR, Lakiza O, Obara T.

Biochem Biophys Res Commun. 2015 Aug 7;463(4):1334-1340. doi: 10.1016/j.bbrc.2015.06.130. Epub 2015 Jun 23.

10.

Differential expression of the transcription factor ARID3a in lupus patient hematopoietic progenitor cells.

Ratliff ML, Ward JM, Merrill JT, James JA, Webb CF.

J Immunol. 2015 Feb 1;194(3):940-9. doi: 10.4049/jimmunol.1401941. Epub 2014 Dec 22.

11.

Disease activity in systemic lupus erythematosus correlates with expression of the transcription factor AT-rich-interactive domain 3A.

Ward JM, Rose K, Montgomery C, Adrianto I, James JA, Merrill JT, Webb CF.

Arthritis Rheumatol. 2014 Dec;66(12):3404-12. doi: 10.1002/art.38857.

12.

Two functional lupus-associated BLK promoter variants control cell-type- and developmental-stage-specific transcription.

Guthridge JM, Lu R, Sun H, Sun C, Wiley GB, Dominguez N, Macwana SR, Lessard CJ, Kim-Howard X, Cobb BL, Kaufman KM, Kelly JA, Langefeld CD, Adler AJ, Harley IT, Merrill JT, Gilkeson GS, Kamen DL, Niewold TB, Brown EE, Edberg JC, Petri MA, Ramsey-Goldman R, Reveille JD, Vilá LM, Kimberly RP, Freedman BI, Stevens AM, Boackle SA, Criswell LA, Vyse TJ, Behrens TW, Jacob CO, Alarcón-Riquelme ME, Sivils KL, Choi J, Joo YB, Bang SY, Lee HS, Bae SC, Shen N, Qian X, Tsao BP, Scofield RH, Harley JB, Webb CF, Wakeland EK, James JA, Nath SK, Graham RR, Gaffney PM.

Am J Hum Genet. 2014 Apr 3;94(4):586-98. doi: 10.1016/j.ajhg.2014.03.008.

13.

The Bright Side of Hematopoiesis: Regulatory Roles of ARID3a/Bright in Human and Mouse Hematopoiesis.

Ratliff ML, Templeton TD, Ward JM, Webb CF.

Front Immunol. 2014 Mar 19;5:113. doi: 10.3389/fimmu.2014.00113. eCollection 2014. Review.

14.

Bright/Arid3A acts as a barrier to somatic cell reprogramming through direct regulation of Oct4, Sox2, and Nanog.

Popowski M, Templeton TD, Lee BK, Rhee C, Li H, Miner C, Dekker JD, Orlanski S, Bergman Y, Iyer VR, Webb CF, Tucker H.

Stem Cell Reports. 2014 Jan 14;2(1):26-35. doi: 10.1016/j.stemcr.2013.12.002. eCollection 2014 Jan 14.

15.

The transcription factor encyclopedia.

Yusuf D, Butland SL, Swanson MI, Bolotin E, Ticoll A, Cheung WA, Zhang XY, Dickman CT, Fulton DL, Lim JS, Schnabl JM, Ramos OH, Vasseur-Cognet M, de Leeuw CN, Simpson EM, Ryffel GU, Lam EW, Kist R, Wilson MS, Marco-Ferreres R, Brosens JJ, Beccari LL, Bovolenta P, Benayoun BA, Monteiro LJ, Schwenen HD, Grontved L, Wederell E, Mandrup S, Veitia RA, Chakravarthy H, Hoodless PA, Mancarelli MM, Torbett BE, Banham AH, Reddy SP, Cullum RL, Liedtke M, Tschan MP, Vaz M, Rizzino A, Zannini M, Frietze S, Farnham PJ, Eijkelenboom A, Brown PJ, Laperrière D, Leprince D, de Cristofaro T, Prince KL, Putker M, del Peso L, Camenisch G, Wenger RH, Mikula M, Rozendaal M, Mader S, Ostrowski J, Rhodes SJ, Van Rechem C, Boulay G, Olechnowicz SW, Breslin MB, Lan MS, Nanan KK, Wegner M, Hou J, Mullen RD, Colvin SC, Noy PJ, Webb CF, Witek ME, Ferrell S, Daniel JM, Park J, Waldman SA, Peet DJ, Taggart M, Jayaraman PS, Karrich JJ, Blom B, Vesuna F, O'Geen H, Sun Y, Gronostajski RM, Woodcroft MW, Hough MR, Chen E, Europe-Finner GN, Karolczak-Bayatti M, Bailey J, Hankinson O, Raman V, LeBrun DP, Biswal S, Harvey CJ, DeBruyne JP, Hogenesch JB, Hevner RF, Héligon C, Luo XM, Blank MC, Millen KJ, Sharlin DS, Forrest D, Dahlman-Wright K, Zhao C, Mishima Y, Sinha S, Chakrabarti R, Portales-Casamar E, Sladek FM, Bradley PH, Wasserman WW.

Genome Biol. 2012;13(3):R24. doi: 10.1186/gb-2012-13-3-r24.

16.

Serum amyloid A protects murine macrophages from lethal toxin-mediated death.

Rose K, Long P, Shankar M, Ballard JD, Webb CF.

Cell Immunol. 2012;272(2):175-81. doi: 10.1016/j.cellimm.2011.10.014. Epub 2011 Oct 29.

17.

The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production.

Oldham AL, Miner CA, Wang HC, Webb CF.

Mol Immunol. 2011 Oct;49(1-2):367-79. doi: 10.1016/j.molimm.2011.09.008. Epub 2011 Oct 2.

18.

Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus.

Adrianto I, Wen F, Templeton A, Wiley G, King JB, Lessard CJ, Bates JS, Hu Y, Kelly JA, Kaufman KM, Guthridge JM, Alarcón-Riquelme ME; BIOLUPUS and GENLES Networks, Anaya JM, Bae SC, Bang SY, Boackle SA, Brown EE, Petri MA, Gallant C, Ramsey-Goldman R, Reveille JD, Vila LM, Criswell LA, Edberg JC, Freedman BI, Gregersen PK, Gilkeson GS, Jacob CO, James JA, Kamen DL, Kimberly RP, Martin J, Merrill JT, Niewold TB, Park SY, Pons-Estel BA, Scofield RH, Stevens AM, Tsao BP, Vyse TJ, Langefeld CD, Harley JB, Moser KL, Webb CF, Humphrey MB, Montgomery CG, Gaffney PM.

Nat Genet. 2011 Mar;43(3):253-8. doi: 10.1038/ng.766. Epub 2011 Feb 20.

19.

The ARID family transcription factor bright is required for both hematopoietic stem cell and B lineage development.

Webb CF, Bryant J, Popowski M, Allred L, Kim D, Harriss J, Schmidt C, Miner CA, Rose K, Cheng HL, Griffin C, Tucker PW.

Mol Cell Biol. 2011 Mar;31(5):1041-53. doi: 10.1128/MCB.01448-10. Epub 2011 Jan 3.

20.

Loss of Bright/ARID3a function promotes developmental plasticity.

An G, Miner CA, Nixon JC, Kincade PW, Bryant J, Tucker PW, Webb CF.

Stem Cells. 2010 Sep;28(9):1560-7. doi: 10.1002/stem.491.

21.

Signalling of the BCR is regulated by a lipid rafts-localised transcription factor, Bright.

Schmidt C, Kim D, Ippolito GC, Naqvi HR, Probst L, Mathur S, Rosas-Acosta G, Wilson VG, Oldham AL, Poenie M, Webb CF, Tucker PW.

EMBO J. 2009 Mar 18;28(6):711-24. doi: 10.1038/emboj.2009.20. Epub 2009 Feb 12.

22.

Transgenic mice expressing dominant-negative bright exhibit defects in B1 B cells.

Nixon JC, Ferrell S, Miner C, Oldham AL, Hochgeschwender U, Webb CF.

J Immunol. 2008 Nov 15;181(10):6913-22.

23.

Retinoids accelerate B lineage lymphoid differentiation.

Chen X, Esplin BL, Garrett KP, Welner RS, Webb CF, Kincade PW.

J Immunol. 2008 Jan 1;180(1):138-45.

24.

Anti-nuclear antibody production and autoimmunity in transgenic mice that overexpress the transcription factor Bright.

Shankar M, Nixon JC, Maier S, Workman J, Farris AD, Webb CF.

J Immunol. 2007 Mar 1;178(5):2996-3006.

25.

Induction of immunoglobulin heavy-chain transcription through the transcription factor Bright requires TFII-I.

Rajaiya J, Nixon JC, Ayers N, Desgranges ZP, Roy AL, Webb CF.

Mol Cell Biol. 2006 Jun;26(12):4758-68.

26.

The divergence of lymphocyte development pathways.

Webb CF, Kincade PW.

J Immunol. 2006 Jun 1;176(11):6369. No abstract available.

27.

Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright.

Rajaiya J, Hatfield M, Nixon JC, Rawlings DJ, Webb CF.

Mol Cell Biol. 2005 Mar;25(6):2073-84.

28.
29.

The transcription factor, Bright, is not expressed in all human B lymphocyte subpopulations.

Nixon JC, Rajaiya JB, Ayers N, Evetts S, Webb CF.

Cell Immunol. 2004 Mar;228(1):42-53.

PMID:
15203319
30.
31.

The transcription factor, Bright, and immunoglobulin heavy chain expression.

Webb CF.

Immunol Res. 2001;24(2):149-61. Review.

PMID:
11594453
32.

The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease.

Webb CF, Yamashita Y, Ayers N, Evetts S, Paulin Y, Conley ME, Smith EA.

J Immunol. 2000 Dec 15;165(12):6956-65.

33.

An upstream Oct-1- and Oct-2-binding silencer governs B29 (Ig beta) gene expression.

Malone CS, Patrone L, Buchanan KL, Webb CF, Wall R.

J Immunol. 2000 Mar 1;164(5):2550-6.

34.

Expression of bright at two distinct stages of B lymphocyte development.

Webb CF, Smith EA, Medina KL, Buchanan KL, Smithson G, Dou S.

J Immunol. 1998 May 15;160(10):4747-54.

35.

Family-specific differences in transcription efficiency of Ig heavy chain promoters.

Buchanan KL, Smith EA, Dou S, Corcoran LM, Webb CF.

J Immunol. 1997 Aug 1;159(3):1247-54.

PMID:
9233620
36.

Interaction of the nuclear matrix-associated region (MAR)-binding proteins, SATB1 and CDP/Cux, with a MAR element (L2a) in an upstream regulatory region of the mouse CD8a gene.

Banan M, Rojas IC, Lee WH, King HL, Harriss JV, Kobayashi R, Webb CF, Gottlieb PD.

J Biol Chem. 1997 Jul 18;272(29):18440-52.

37.

Reassessment of germline heavy chain transcripts from two murine VH families.

Webb CF, Dou S, Buchanan KL, Resta R, Smithson G, Smith EA.

Mol Immunol. 1997 Jul;34(10):743-50.

PMID:
9430202
38.

Isolation and characterization of the promoter of the human 5'-nucleotidase (CD73)-encoding gene.

Hansen KR, Resta R, Webb CF, Thompson LF.

Gene. 1995 Dec 29;167(1-2):307-12.

PMID:
8566797
39.

Differential transcription efficiency of two Ig VH promoters in vitro.

Buchanan KL, Hodgetts SI, Byrnes J, Webb CF.

J Immunol. 1995 Nov 1;155(9):4270-7.

PMID:
7594585
40.

Ecto-5'-nucleotidase (CD73): genomic cloning and characterization of regions upstream of the translation start site.

Hansen KR, Resta R, Webb CF, Thompson LF.

Adv Exp Med Biol. 1994;370:689-92. No abstract available.

PMID:
7660997
41.

Mechanisms of radiosensitization in bromodeoxyuridine-substituted cells.

Webb CF, Jones GD, Ward JF, Moyer DJ, Aguilera JA, Ling LL.

Int J Radiat Biol. 1993 Dec;64(6):695-705.

PMID:
7903337
42.
43.

Identification of a matrix-associated region 5' of an immunoglobulin heavy chain variable region gene.

Webb CF, Das C, Eneff KL, Tucker PW.

Mol Cell Biol. 1991 Oct;11(10):5206-11.

44.
45.

Induction of immunoglobulin mu mRNA in a B cell transfectant stimulated with interleukin-5 and a T-dependent antigen.

Webb CF, Das C, Coffman RL, Tucker PW.

J Immunol. 1989 Dec 15;143(12):3934-9.

PMID:
2480380
46.

Expression and sequence analyses of serum amyloid A in the Syrian hamster.

Webb CF, Tucker PW, Dowton SB.

Biochemistry. 1989 May 30;28(11):4785-90.

PMID:
2765510
47.

Immunoglobulin receptor signaling depends on the carboxyl terminus but not the heavy-chain class.

Webb CF, Nakai C, Tucker PW.

Proc Natl Acad Sci U S A. 1989 Mar;86(6):1977-81.

48.

Regulation of an idiotype+ B cell lymphoma. Effects of antigen and anti-idiotopic antibodies on proliferation and Ig secretion.

Ward RE, McNamara-Ward M, Webb CF, Altman D, Lim PL, Tucker PW, Kohler H.

J Immunol. 1988 Jul 1;141(1):340-6.

PMID:
3259969
50.

Supplemental Content

Support Center